A new form of inhaled insulin appears to help people with diabetes who must use insulin, with fewer potential risks than an earlier form of inhaled insulin that is no longer on the market. The new drug, Afrezza, which is awaiting approval from the U.S. Food and Drug Administration, works faster, keeps blood sugar levels at a closer to normal level and has less risk of causing low blood sugar levels (hypoglycemia) than currently available injectable insulins, researchers say.
Study shows that lax parental oversight leads to poor juvenile diabetes management. A CT (computed tomography) scanner takes multiple X-rays of your body and assembles the "slices," as thin as 1/50th of an inch, into a 3-D image. You will get an IV injection of a contrast dye first, to highlight the tissue of interest. Then you'll lie flat on a table and positioned inside a ring like a large doughnut.